On Tuesday, Jaguar Health Inc (NASDAQ: JAGX) opened lower -12.74% from the last session, before settling in for the closing price of $0.86. Price fluctuations for JAGX have ranged from $0.78 to $21.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 41.53% annually for the last half of the decade. Company’s average yearly earnings per share was noted 99.26% at the time writing. With a float of $12.45 million, this company’s outstanding shares have now reached $16.31 million.
In an organization with 49 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 68.65%, operating margin of -284.92%, and the pretax margin is -365.71%.
Jaguar Health Inc (JAGX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Jaguar Health Inc is 23.67%, while institutional ownership is 1.72%.
Jaguar Health Inc (JAGX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 99.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 79.17% during the next five years compared to 86.10% growth over the previous five years of trading.
Jaguar Health Inc (NASDAQ: JAGX) Trading Performance Indicators
Check out the current performance indicators for Jaguar Health Inc (JAGX). In the past quarter, the stock posted a quick ratio of 1.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -16.10, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -2.06 in one year’s time.
Technical Analysis of Jaguar Health Inc (JAGX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.51 million. That was better than the volume of 0.42 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 25.29%. Additionally, its Average True Range was 0.09.
During the past 100 days, Jaguar Health Inc’s (JAGX) raw stochastic average was set at 2.15%, which indicates a significant decrease from 4.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 110.42% in the past 14 days, which was higher than the 100.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9381, while its 200-day Moving Average is $2.4755. However, in the short run, Jaguar Health Inc’s stock first resistance to watch stands at $0.8271. Second resistance stands at $0.9071. The third major resistance level sits at $0.9545. If the price goes on to break the first support level at $0.6997, it is likely to go to the next support level at $0.6523. Assuming the price breaks the second support level, the third support level stands at $0.5723.
Jaguar Health Inc (NASDAQ: JAGX) Key Stats
There are currently 11,798K shares outstanding in the company with a market cap of 12.18 million. Presently, the company’s annual sales total 9,760 K according to its annual income of -41,300 K. Last quarter, the company’s sales amounted to 3,110 K and its income totaled -9,850 K.
